Form 8-K - Current report:
SEC Accession No. 0001437749-25-014147
Filing Date
2025-05-01
Accepted
2025-05-01 16:58:27
Documents
16
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20250430_8k.htm   iXBRL 8-K 27432
2 EXHIBIT 99.1 ex_809992.htm EX-99.1 81356
7 logosm.jpg GRAPHIC 12780
  Complete submission text file 0001437749-25-014147.txt   291651

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20250501.xsd EX-101.SCH 4060
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20250501_def.xml EX-101.DEF 13442
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20250501_lab.xml EX-101.LAB 17669
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20250501_pre.xml EX-101.PRE 13419
18 EXTRACTED XBRL INSTANCE DOCUMENT govx20250430_8k_htm.xml XML 4794
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 25904144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)